Active · per the CBE, 17 November 2026

Scaldis Pharma

BE0803923429

Rechtspersoon Private limited company 1 establishment

Scaldis Pharma is an engineering firm in Aalst. Private Limited, started on 13 July 2023, 1 establishment.

Kapittelstraat 75, 9310 Aalst

Behind the company: Maxim Van Den Steen.

Active for

3 year, 4 months

Financials

Financial year 2025

Scaldis Pharma from Aalst, company number BE0803923429, closed financial year 2025 with a result of € -14,039 after tax. For that financial year Scaldis Pharma recorded a gross margin of € 54,532 and equity of € 5,697. Compared with financial year 2024, the result moved from € 24,009 to € -14,039. The company made a loss. The buffer shrank hard: equity is 84 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 5,697

▼ 84% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -14,039

▼ still € 24,009 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 20,602

▼ 32% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 697.

People and assets in 2025

Full-time equivalents estimate

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 30,736

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,145

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go

€ 211,366

€ 28,468 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 4,145

▲ € 3,758 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 10,329

▼ 33% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
202320242025Change 2024 → 2025
Gross margin € 9,087 € 36,248 € 54,532 ▲ 50%
Profit after taxes € 5,727 € 24,009 € -14,039 ▼ € 38,047
Equity € 10,727 € 34,735 € 5,697 ▼ 84%
Total debts € 24,701 € 16,106 € 245,464 ▲ € 229,358
Cash € 14,916 € 30,386 € 20,602 ▼ 32%
Land & buildings - - € 48,600
Retained profit € 5,727 € 29,735 € 697 ▼ 98%
Dividend € 0 € 0 € 15,000
Bank debt € 0 € 0 € 211,366
Balance sheet total € 35,427 € 50,842 € 251,161 ▲ € 200,319

By gross margin, Scaldis Pharma ranks 1st of 4 companies with main activity “Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts” in Aalst that publish figures (fiscal year 2025).

Key figures of Scaldis Pharma, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Scaldis Pharma?

What happened at Scaldis Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 14,039 (▼ € 38,047 vs 2024). Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Aalst. KBO
  • Maxim Van Den Steen became a director. NBB

In short

From € 5,727 profit in 2023 to € 14,039 loss in 2025.

Paid € 10,365 in corporate taxes since 2023.

Best year ever: 2024, with € 24,009 profit.

Paid out € 15,000 in dividends to the owners in total.

Management

Maxim Van Den Steen
Scaldis Pharma

Behind Scaldis Pharma is Maxim Van Den Steen.

Directors

According to the 2025 annual accounts

Maxim Van Den Steen

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Kapittelstraat 75

9310 Aalst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Aalst

Same main activity (Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts), 3 active companies in Aalst, largest first.

D.S.S.

€ 47,632 gross margin · 2025

INTREX

€ 9,480 gross margin · 2025

E.R.E.

€ -4,685 gross margin · 2025

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Van den Steen Maxim(oprichter) 100%

Details

Company number
0803.923.429
VAT number
BE 0803.923.429
Registered office
Kapittelstraat 75, 9310 Aalst
Names & denominations
Scaldis Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
13 July 2023
Peppol
Active · Active since 21 Oct 2026
Activities · NACE

Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts

Vervaardiging van geneesmiddelen

Frequently asked questions

What does Scaldis Pharma do?
Scaldis Pharma is an engineering firm in Aalst. Private Limited, started on 13 July 2023, 1 establishment.
What is the address of Scaldis Pharma?
The registered office of Scaldis Pharma is located at Kapittelstraat 75, 9310 Aalst.
Is Scaldis Pharma still active?
Yes. According to the CBE (17 November 2026) Scaldis Pharma is active, legal situation “Normale toestand”, started on 13 July 2023.
Is Scaldis Pharma registered on Peppol?
Yes, Scaldis Pharma is registered on the Peppol network with ID 0208:0803923429.
What is the enterprise number of Scaldis Pharma?
The enterprise number of Scaldis Pharma is BE0803923429.
When was Scaldis Pharma founded?
Scaldis Pharma was founded on 13 July 2023.